Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Dow
Express Scripts
AstraZeneca
Merck

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Avanthi Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AVANTHI INC, and what generic and branded alternatives to AVANTHI INC drugs are available?

AVANTHI INC has ten approved drugs.



Summary for Avanthi Inc
US Patents:0
Tradenames:9
Ingredients:9
NDAs:10

Drugs and US Patents for Avanthi Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avanthi Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 091393-003 Aug 31, 2009 AB RX No No   Start Trial   Start Trial
Avanthi Inc DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 078648-001 Feb 27, 2013 DISCN No No   Start Trial   Start Trial
Avanthi Inc OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET;ORAL 203601-002 Jan 30, 2013 AB RX No No   Start Trial   Start Trial
Avanthi Inc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride CAPSULE;ORAL 202773-001 Aug 17, 2015 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
AstraZeneca
Moodys
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.